These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 17650609)
21. [Creation of collateral circulation in the internal membranes of the eye]. Voloshinov DB Vestn Oftalmol; 1971; 4():44-8. PubMed ID: 5143609 [No Abstract] [Full Text] [Related]
22. [Therapeutic viewpoints in disorders of the terminal vascular bed]. Ehrly AM Med Welt; 1974 Jul; 25(27-28):1221-4. PubMed ID: 4471937 [No Abstract] [Full Text] [Related]
23. [Aging processes and the eye]. Kashintseva LT Oftalmol Zh; 1980; 35(7):387-91. PubMed ID: 7010250 [No Abstract] [Full Text] [Related]
24. An attempted synopsis of the physiology and pathology of the systemic and ocular arterial system. Thiel R S Afr Med J; 1966 Sep; 40(33):777-83. PubMed ID: 5920619 [No Abstract] [Full Text] [Related]
27. [Place of macromolecular preparations in ophthalmological therapy]. Fodor F; Sireteanu L; Csiszár A Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1978; 27(2):123-5. PubMed ID: 674721 [No Abstract] [Full Text] [Related]
28. [New therapeutical perspectives in ophthalmology]. Riu R; Darleguy P; Gacon R Therapeutique; 1970 Nov; 46(9):925-8. PubMed ID: 5486143 [No Abstract] [Full Text] [Related]
29. [Ultrastructural aspects of the action of a phlebotropic drug]. Martines G; Antonioli GE; Musacci GF Minerva Cardioangiol; 1972 Oct; 20(10):582-97. PubMed ID: 5080092 [No Abstract] [Full Text] [Related]
33. [Clinical and experimental study of the action of triethylene-thiophosphoramide on corneal vascularization]. Lavergne G Bull Mem Soc Fr Ophtalmol; 1967; 80():146-55. PubMed ID: 4998888 [No Abstract] [Full Text] [Related]
34. Treatment of ocular symptoms in myasthenia gravis. Bhanushali MJ; Wuu J; Benatar M Neurology; 2008 Oct; 71(17):1335-41. PubMed ID: 18936425 [TBL] [Abstract][Full Text] [Related]
35. Recent advances in drug delivery systems for treating ocular complications of systemic diseases. Lee SS; Hughes PM; Robinson MR Curr Opin Ophthalmol; 2009 Nov; 20(6):511-9. PubMed ID: 19667987 [TBL] [Abstract][Full Text] [Related]
37. [Role of disorders in the autoregulation of the intraocular blood circulation in the development of dystrophic changes in eye tissues]. Kornilovskiĭ IM Oftalmol Zh; 1982; 37(8):477-80. PubMed ID: 7162741 [No Abstract] [Full Text] [Related]
38. L-carnitine and its derivatives: a promising future in the treatment of ocular disorders. Feher J Drugs R D; 2008; 9 Suppl 1():33-4. PubMed ID: 19105590 [No Abstract] [Full Text] [Related]
39. The impact of novel treatment modalities on the therapeutic approach of cardiovascular diseases. Paraskevas KI; Psathas C; Dragios T; Chatzis DG; Mikhailidis DP; Kyriakides ZS Angiology; 2009; 60(1):5-7. PubMed ID: 19190028 [No Abstract] [Full Text] [Related]
40. [Results of research in the field of vascular eye pathology]. Trutneva KV; Shul'pina NB Vestn Oftalmol; 1977; (5):48-53. PubMed ID: 906207 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]